Granules India has received its board approval to close Granules Singapore, wholly owned subsidiary of the Company (WOS), located at Singapore. The board at its meeting held on October 30, 2013 has approved the same.
Granules India is a fast growing pharmaceutical manufacturing company with world class facilities and is committed to manufacturing excellence, quality and customer service. The Company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) for quality conscious customers in the regulated and semi-regulated markets.
